Novel sst4-Selective Somatostatin (SRIF) Agonists. 3. Analogues Amenable to Radiolabeling

Journal of Medicinal Chemistry

Volumn 46, Issue 26, 2003, Pages 5597-5605

  Erchegyi, Judit ^a   Waser, Beatrice ^b   Schaer, Jean Claude ^a   Cescato, Renzo ^b   Brazeau, Jean François ^a   Rivier, Jean ^a   Reubi, Jean Claude ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLIC AMP; FORSKOLIN; PHENYLALANINE DERIVATIVE; SOMATOSTATIN; SOMATOSTATIN AGONIST; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CARBAMOYLATION; IODINATION; ISOTOPE LABELING; RECEPTOR BINDING;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; CELL LINE; CRICETINAE; CYCLIC AMP; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; LIGANDS; MEMBRANE PROTEINS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0346487259     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030245x     Document Type: Article

References (44)

1. 4-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. J. Med. Chem. 2003, 46, 5579-5586 (in this issue).
2. Bruno, J. F.; Xu, Y.; Song, J.; Berelowitz, M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11151-11155.
3. Yasuda, K.; Rens-Domiano, S.; Breder, C. D.; Law, S. F.; Saper, C. B.; Reisine, T.; Bell, G. I. Cloning of a novel somatostatin receptor, SSTR3, that is coupled to adenylyl cyclase. J. Biol. Chem. 1992, 267, 20422-20428.
4. Rohrer, L.; Raulf, F.; Bruns, C.; Buettner, R.; Hofstaedter, F.; Schule, R. Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 4196-4200.
5. Xu, Y.; Song, H.; Bruno, J. F.; Berelowitz, M. Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4. Biochem. Biophys. Res. Commun. 1993, 193, 648-652.
6. Yamada, Y.; Post, S. R.; Wang, K.; Medical, H.; Tager, S.; Bell, G. I.; Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 251-255.
7. Yamada, Y.; Reisine, T.; Law, S. F.; Ihara, Y.; Kubota, A.; Kagimoto, S. ; Seino, M.; Seino, Y.; Bell, G. I.; Seino, S. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol. 1992, 6, 2136-2142.
8. Yamada, Y.; Kagimoto, S.; Kubota, A.; Yasuda, K.; Masuda, K.; Someya, Y. ; Ihara, Y.; Li, Q.; Imura, H.; Seino, S.; Seino, Y. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res. Commun. 1993, 195, 844-852.
9. Patel, Y. C. Somatostatin and its receptor family. Front. Neuroendocrinol. 1999, 20, 157-198.
10. 1). J. Med. Chem. 2001, 44, 2238-2246.
11. Reubi, J. C.; Schaer, J.-C.; Wenger, S.; Hoeger, C.; Erchegyi, J.; Waser, B.; Rivier, J. SST3-selective potent peptidic somatostatin receptor antagonists. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13973-13978.
12. 4-selective somatostatin (SRIF) agonists. 2. Analogues with β-methyl-3-(2-naphthyl)alanine substitutions at position 8. J. Med. Chem. 2003, 46, 5587-5596 (in this issue).
13. 4). Proceedings of the 27th European Peptide Symposium, Sorrento, Italy; Edizioni Ziino: Napoli, Italy, 2002; pp 474-475.
14. Lewis, I.; Bauer, W.; Albert, R.; Chandramouli, N.; Pless, J.; Weckbecker, G.; Bruns, C. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J. Med. Chem. 2003, 46, 2334-2344.
15. Snyder, H. R.; Matteson, D. S. The synthesis of the 2-amino-3-(3-indolyl)-butyric acids (β-methyltryptophans). J. Am. Chem. Soc. 1957, 79, 2217-2221.
16. Miller, C.; Rivier, J. Peptide chemistry: Development of high-performance liquid chromatography and capillary zone electrophoresis. Biopolymers 1996, 40, 265-317.
17. Miller, C.; Rivier, J. Analysis of synthetic peptides by capillary zone electrophoresis in organic/aqueous buffers. J. Pept. Res. 1998, 51, 444-451.
18. Reubi, J. C.; Schaer, J. C.; Waser, B.; Wenger, S.; Heppeler, A.; Schmitt, J. S.; Mäcke, H. R. Affinity profiles for human somatostatin receptor sst1-sst5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur. J. Nucl. Med. 2000, 27, 273-282.
19. 1-receptor subtype expressed by human tumors. Eur. J. Pharmacol. 1998, 345, 103-110.
20. Reubi, J. C. In vitro identification of vasoactive intestinal peptide receptors in human tumors: Implications for tumor imaging. J. Nucl. Med. 1995, 36, 1846-1853.
21. Brazeau, P.; Vale, W. W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J. E.; Guillemin, R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179, 77-79.
22. Huang, Z.; He, Y.; Raynor, K.; Tallent, M.; Reisine, T.; Goodman, M. Side chain chiral methylated somatostatin analog synthesis and conformational analysis. J. Am. Chem. Soc. 1992, 114, 9390-9401.
23. Patel, Y. C.; Panetta, R.; Escher, E.; Greenwood, M.; Srikant, C. B. Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J. Biol. Chem. 1994, 269, 1506-1509.
24. Rivier, J.; Brown, M.; Vale, W. Tyrosylated analogs of somatostatin. J. Med. Chem. 1976, 19, 1010-1013.
25. Schulz, S.; Pauli, S. U.; Handel, M.; Dietzmann, K.; Firsching, R.; Hollt, V. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin. Cancer Res. 2000, 6, 1865-1874.
26. Rohrer, S. P.; Birzin, E. T.; Mosley, R. T.; Berk, S. C.; Hutchins, S. M.; Shen, D.-M.; Xiong, Y.; Hayes, E. C.; Parmar, R. M.; Foor, F.; Mitra, S. W. ; Degrado, S. J.; Shu, M.; Klopp, J. M.; Cai, S.-J.; Blake, A.; Chan, W. W. S.; Pasternak, A.; Yang, L.; Patchett, A. A.; Smith, R. G.; Chapman, K. T.; Schaeffer, J. M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 1998, 282, 737-740.
27. Harrington, K. A.; Schindler, M.; Humphrey, P. P.; Emson, P. C. Expression of messenger RNA for somatostatin receptor subtype 4 in adult rat brain. Neurosci. Lett. 1995, 188, 17-20.
28. Schloos, J.; Raulf, F.; Hoyer, D.; Bruns, C. Identification and pharmacological characterization of somatostatin receptors in rat lung. Br. J. Pharmacol. 1997, 121, 963-971.
29. Caron, P.; Buscail, L.; Beckers, A.; Esteve, J. P.; Igout, A.; Hennen, G.; Susini, C. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J. Clin. Endocrinol. Metab. 1997, 82, 3771-3776.
30. Jais, P.; Terris, B.; Ruszniewski, P.; LeRomancer, M.; Reyl-Desmars, F.; Vissuzaine, C.; Cadiot, G.; Mignon, M.; Lewin, M. J. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. Eur. J. Clin. Invest. 1997, 27, 639-644.
31. Panetta, R.; Patel, Y. C. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci. 1995, 56, 333-342.
32. Ain, K. B.; Taylor, K. D.; Tofiq, S.; Venkataraman, G. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 1997, 82, 1857-1862.
33. Hansson, J.; Bjartell, A.; Gadaleanu, V.; Dizeyi, N.; Abrahamsson, P. A. Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer. Prostate 2002, 53, 50-59.
34. Reubi, J. C.; Waser, B.; Schaer, J.-C.; Laissue, J. A. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur. J. Nucl. Med. 2001, 28, 836-846.
35. Krenning, E. P.; Kwekkeboom, D. J.; Pauwels, S.; Kvols, L. K.; Reubi, J. C. Somatostatin receptor scintigraphy. Nuclear Medicine Annual 1995; Raven Press: Ltd.: New York, 1995; pp 1-50.
36. Otte, A.; Mueller-Brand, J.; Dellas, S.; Nitzsche, E. U.; Herrmann, R.; Maecke, H. R. Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet 1998, 351, 417-418.
37. 4-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR. 2003, 46, 5606-5618 (in this issue).
38. Horiki, K.; Igano, K.; Inouye, K. Amino acids and peptides. Part 6. Synthesis of the Merrifield resin esters of N-protected amino acids with the aid of hydrogen bonding. Chem. Lett. 1978, 2, 165-168.
39. Rivier, J.; Porter, J.; Hoeger, C.; Theobald, P.; Craig, A. G.; Dykert, J.; Corrigan, A.; Perrin, M.; Hook, W. A.; Siraganian, R. P.; Vale, W.; Rivier, C. Gonadotropin releasing hormone antagonists with Nω-triazolyl-ornithine, -lysine or -para-aminophenylalanine residues at positions 5 and 6. J. Med. Chem. 1992, 35, 4270-4278.
40. Hoeger, C. A.; Galyean, R. F.; Boublik, J.; McClintock, R. A.; Rivier, J. E. Preparative reversed phase high performance liquid chromatography. II. Effects of buffer pH on the purification of synthetic peptides. Biochromatography 1987, 2, 134-142.
41. Shoji, J.-I.; Tori, K.; Otsuka, H. Configuration of N,β -dimethylleucine, a constituent amino acid of triostin C. J. Org. Chem. 1964, 30, 2772-2776.
42. Kataoka, Y.; Seto, Y.; Yamamoto, M.; Yamada, T.; Kuwata, S.; Watanabe, H. Studies of unusual amino acids and their peptides. VI. The syntheses and the optical resolutions of β-methylphenylalanine and its dipeptide present in bottromycin. Bull. Chem. Soc. Jpn. 1976, 49, 1081-1084.
43. Stewart, J. M.; Young, J. D. Solid-Phase Peptide Synthesis. Solid-Phase Peptide Synthesis, 2nd ed.; Pierce Chemical Co.: Rockford, IL, 1984; p 176.
44. Reubi, J. C.; Eisenwiener, K. P.; Rink, H.; Waser, B.; Macke, H. R. A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. Eur. J. Pharmacol. 2002, 456, 45-49.